Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Amatangelo, Michael D.
31  Ergebnisse:
Personensuche X
?
1

Pharmacodynamic changes in tumor and immune cells drive ibe..:

Amatangelo, Michael ; Flynt, Erin ; Stong, Nicholas...
Cell Reports Medicine.  5 (2024)  6 - p. 101571 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Iberdomide increases innate and adaptive immune cell subset..:

Van Oekelen, Oliver ; Amatangelo, Michael ; Guo, Manman...
Cell Reports Medicine.  5 (2024)  6 - p. 101584 , 2024
Link: https://doi.org/10.1016/..
 
?
3

OA-49 Mezigdomide (MEZI) plus dexamethasone (DEX) and borte..:

Oriol, Albert ; Sandhu, Irwindeep ; Raab, Marc...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S31 , 2023
Link: https://doi.org/10.1016/..
 
?
4

MM-360 Mezigdomide (MEZI) Plus Dexamethasone (DEX) in Relap..:

Orlowski, Robert Z. ; Bahlis, Nizar J. ; Quach, Hang...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S492-S493 , 2023
Link: https://doi.org/10.1016/..
 
?
5

MM-372 A Phase III, Two-Stage, Randomized Study of Mezigdom..:

Richardson, Paul G. ; Badelita, Sorina N. ; Besemer, Britta...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S495-S496 , 2023
Link: https://doi.org/10.1016/..
 
?
6

POSTER: MM-360 Mezigdomide (MEZI) Plus Dexamethasone (DEX) ..:

Orlowski, Robert Z. ; Bahlis, Nizar J. ; Quach, Hang...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S226 , 2023
Link: https://doi.org/10.1016/..
 
?
7

P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIEN..:

Bahlis, Nizar J ; Trudel, Suzanne ; Quach, Hang...
HemaSphere.  7 (2023)  S3 - p. e7140563 , 2023
Link: https://doi.org/10.1097/..
 
?
8

P-381 Mezigdomide (CC-92480) activates innate and adaptive ..:

Chen, Lucia ; Amatangelo, Michael ; van Oekelen, Oliver...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S250 , 2023
Link: https://doi.org/10.1016/..
 
?
9

POSTER: MM-372 A Phase III, Two-Stage, Randomized Study of ..:

Richardson, Paul G. ; Badelita, Sorina N. ; Besemer, Britta...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S228 , 2023
Link: https://doi.org/10.1016/..
 
?
10

OA-41 Iberdomide, bortezomib, and dexamethasone (IberVd) in..:

White, Darrell ; Lipe, Brea ; Mesa, Mercedes Gironella...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S25 , 2023
Link: https://doi.org/10.1016/..
 
?
11

P-137 A phase 3, two-stage, randomized study of iberdomide ..:

Gay, Francesca ; Dimopoulos, Meletios ; Huang, Xiaojun...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S111 , 2023
Link: https://doi.org/10.1016/..
 
?
12

P-230: Preclinical and translational biomarker analysis to ..:

Amatangelo, Michael ; Bjorklund, Chad C. ; Hagner, Patrick...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S161-S162 , 2022
Link: https://doi.org/10.1016/..
 
?
13

P-093: Iberdomide induces activation and proliferation of i..:

Van Oekelen, Oliver ; Amatangelo, Michael ; Guo, Manman...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S86-S87 , 2022
Link: https://doi.org/10.1016/..
 
?
14

P-231: Biomarker analysis to support dose optimization of i..:

Amatangelo, Michael ; Cheng, Yiming ; Pierceall, William...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S162 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Developing next generation immunomodulatory drugs and their..:

Thakurta, Anjan ; Pierceall, William E. ; Amatangelo, Michael D...
Oncotarget.  12 (2021)  15 - p. 1555-1563 , 2021
Link: https://doi.org/10.18632..
 
1-15